U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07892300) titled 'Implantable Microdevices for in Situ Evaluation of Drug Responses in Lung Cancer' on Oct. 17.
Brief Summary: This research is being done to study the safety and feasibility of implanting and retrieving a microdevice that releases microdoses of 20 specific drugs or drug combinations as a possible tool to evaluate the effectiveness of several cancer drugs against lung cancer or mesothelioma.
The name of the intervention(s) involved in this study are:
Implantable Microdevice (IMD) Surgery (excision of tumor) Drugs used in this study will include drugs already used as standard of care for the treatment of lung cancer and mesothelioma,...